Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/28/2014US20140243414 Pharmaceutical compositions of cetp inhibitors
08/28/2014US20140243413 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
08/28/2014US20140243410 Compositions for use in surgery
08/28/2014US20140243409 Pharmaceutical compositions having desirable bioavailability
08/28/2014US20140243408 Use of aminoacetonitrile derivatives against endoparasites
08/28/2014US20140243406 Methods for Treating or Preventing Fatigue
08/28/2014US20140243405 A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (cbdv) and cannabidiol (cbd)
08/28/2014US20140243403 Treating colorectal, pancreatic, and lung cancer
08/28/2014US20140243402 Artemisinins in the Clinical and Veterinary Management of Kinetoplastid Infextions
08/28/2014US20140243400 Compositions comprising citric acid and malic acid and methods and uses thereof
08/28/2014US20140243397 Cxcr4 inhibiting carriers for nucleic acid delivery
08/28/2014US20140243396 Method of treating mucoepidermoid carcinoma
08/28/2014US20140243395 Spray system for production of a matrix formed in situ
08/28/2014US20140243390 Novel kif5b-ret fusion molecules and uses thereof
08/28/2014US20140243389 Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
08/28/2014US20140243386 Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
08/28/2014US20140243385 Dithiol Compounds, Derivatives, and Uses Therefor
08/28/2014US20140243384 Use of melatonin for treating and/or preventing mucositis
08/28/2014US20140243383 Pharmaceutical compositions of silodosin
08/28/2014US20140243380 Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
08/28/2014US20140243379 Adhesive mixture for transdermal delivery of highly plasticizing drugs
08/28/2014US20140243378 Compositions and Methods for the Treatment of Muscular Disease, and Related Screening Methods
08/28/2014US20140243372 Benzoic acid derivative mdm2 inhibitor for the treatment of cancer
08/28/2014US20140243370 Pyrano[3,2-D][1,3]thiazole as glycosidase inhibitors
08/28/2014US20140243364 Enhanced stability of novel liquid compositions
08/28/2014US20140243363 Methods and compositions for treating anxiety disorders or symptoms thereof
08/28/2014US20140243361 Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
08/28/2014US20140243359 Adenine derivatives having immunomodulating anti-inflammatory and analgesic activity
08/28/2014US20140243357 Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
08/28/2014US20140243354 Combinations of indigo naturalis and berberine and uses thereof
08/28/2014US20140243353 5- or 6-substituted 3-hydroxy-2(1h)-pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and paid
08/28/2014US20140243351 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist
08/28/2014US20140243350 Use of serotonin receptor agonists for treatment of movement disorders
08/28/2014US20140243348 Compositions and methods for treating herpes viruses
08/28/2014US20140243347 SUBSTITUTED 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1(2H)-ONE DERIVATIVES AS KINASES INHIBITORS
08/28/2014US20140243346 Ip receptor agonist heterocyclic compounds
08/28/2014US20140243344 Combination als therapy
08/28/2014US20140243342 Compositions and methods for prophylaxis and therapy for menieres disease
08/28/2014US20140243341 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
08/28/2014US20140243340 Cytochrome p450 oxidase inhibitors and uses thereof
08/28/2014US20140243339 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
08/28/2014US20140243337 Phenyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
08/28/2014US20140243336 2-Pyridyl Carboxamide-Containing Spleen Tyrosine Kinase (SYK) Inhibitors
08/28/2014US20140243332 Methods of treating cancers characterized by aberrent ros1 activity
08/28/2014US20140243328 Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof
08/28/2014US20140243327 Riminophenazines with 2-(heteroaryl) amino substituents and their anti-microbial activity
08/28/2014US20140243319 Treatments targeting gamma-synuclein expression levels
08/28/2014US20140243311 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
08/28/2014US20140243306 Novel pyrrolo pyrimidine derivatives
08/28/2014US20140243304 Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
08/28/2014US20140243303 Spirocyclic molecules as protein kinase inhibitors
08/28/2014US20140243302 Bridged bicyclic compounds for the treatment of bacterial infections
08/28/2014US20140243300 Controlling the Bioavailability of Active Ingredients in Topical Formulations
08/28/2014US20140243299 Topical Formulations of Corticosteroids with Enhanced Bioavailability
08/28/2014US20140243298 C-3 alkyl and alkenyl modified betulinic acid derivatives
08/28/2014US20140243297 Petroleum jelly-free unguent compositions comprising vitamin d compounds and optionally steroidal anti-inflammatory agents
08/28/2014US20140243296 Organic Compounds
08/28/2014US20140243295 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
08/28/2014US20140243294 Method of activation of oxazaphosphorines
08/28/2014US20140243289 Prodrugs of modulators of abc transporters
08/28/2014US20140243286 Bromodomain ligands capable of dimerizing in an aqueous solution, and methods of using same
08/28/2014US20140243285 Lipid-containing psa compositions, methods of isolation and methods of use thereof
08/28/2014US20140243284 Biologically active macrolides, compositions, and uses thereof
08/28/2014US20140243279 Methods and compositions comprising rifabutin, clarithromycin, and clofazimine
08/28/2014US20140243275 Galectin-3C Combination Therapy for Human Cancer
08/28/2014US20140243273 Methods for treating inflammatory diseases and pharmaceutical combinations useful therefor
08/28/2014US20140243267 Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
08/28/2014US20140243263 Method of enhancing diabetes resolution
08/28/2014US20140243262 Pharmaceutical formulations containing an sglt2 inhibitor
08/28/2014US20140243261 Method for treating diabetes and fatty liver disese by stimulating cellular metabolism
08/28/2014US20140243259 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
08/28/2014US20140243255 Treatments for mycobacterium tuberculosis
08/28/2014US20140243197 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
08/28/2014US20140243195 N-Thio-anthranilamide compounds and their use as pesticides
08/28/2014US20140242204 Pharmaceutical composition including c3g or mulberry extracts containing c3g for preventing or treating diabetic impotence
08/28/2014US20140242201 Compositions for increasing human growth hormone levels
08/28/2014US20140242198 Botanical antimicrobial compositions
08/28/2014US20140242192 Clusterin Antisense Therapy for Treatment of Cancer
08/28/2014US20140242190 Use of deoxyelephantopin (det) and analogues thereof for treatment of melanoma
08/28/2014US20140242189 Methods of treating gastrointestinal spasms triggered by stress
08/28/2014US20140242184 Compositions for Regenerating Defective or Absent Myocardium
08/28/2014US20140242179 Novel coating system
08/28/2014US20140242178 Taste-masked formulations of raltegravir
08/28/2014US20140242177 Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine
08/28/2014US20140242176 Compositions, methods, and devices for the treatment of eye stain
08/28/2014US20140242174 Treating cough and tussive attacks
08/28/2014US20140242172 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/28/2014US20140242171 Oil-in-water emulsion of mometasone and propylene glycol
08/28/2014US20140242170 Corticosteroids for the Treatment of Joint Pain
08/28/2014US20140242169 Tapentadol compositions
08/28/2014US20140242168 Swellable coated tablet
08/28/2014US20140242167 Pharmaceutical compositions for glucocorticoid replacement therapy
08/28/2014US20140242166 Sustained release matrix systems for highly soluble drugs
08/28/2014US20140242163 Amantadine compositions and methods of use
08/28/2014US20140242162 Pharmaceutical compositions comprising 40 - o - ( 2 - hydroxy) ethyl - rapamycin
08/28/2014US20140242161 Soft gelatin capsules
08/28/2014US20140242159 Method for Preparing a Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients
08/28/2014US20140242156 Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
08/28/2014US20140242154 Compounds, Compositions, Methods, and Kits Relating to Telomere Extension
08/28/2014US20140242153 Novel encochleation methods, cochleates and methods of use
1 ... 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 ... 7860